Activity in this selectioncambridge-capital-group-0b92e418
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $3.8M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionSemarionDevelops next-generation cell assay technology for drug discovery
Role not disclosed